Il Dong Pharmaceutical Co Ltd (249420) - Total Liabilities

Latest as of September 2025: ₩347.04 Billion KRW ≈ $235.18 Million USD

Based on the latest financial reports, Il Dong Pharmaceutical Co Ltd (249420) has total liabilities worth ₩347.04 Billion KRW (≈ $235.18 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Il Dong Pharmaceutical Co Ltd (249420) cash conversion ratio to assess how effectively this company generates cash.

Il Dong Pharmaceutical Co Ltd - Total Liabilities Trend (2016–2024)

This chart illustrates how Il Dong Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Check 249420 financial resilience to evaluate the company's liquid asset resilience ratio.

Il Dong Pharmaceutical Co Ltd Competitors by Total Liabilities

The table below lists competitors of Il Dong Pharmaceutical Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Hefei Kewell Power System Co Ltd SHG:688551	China	CN¥408.18 Million
BETTERWARE DE MEXICO SAPI F:BM0	Germany	€8.81 Billion
Wuhan Langold Real Estate Co Ltd SHE:002305	China	CN¥21.71 Billion
Changzhou Architectural Research Institute Group Co. Ltd. A SHE:301115	China	CN¥1.06 Billion
Duzhe Publishing & Media Corp SHG:603999	China	CN¥514.03 Million
Mills Estruturas e Serviços de Engenharia S.A SA:MILS3	Brazil	R$2.80 Billion
SNT Motiv Co Ltd KO:064960	Korea	₩259.97 Billion
Regulus Therapeutics Inc NASDAQ:RGLS	USA	$5.80 Million

Liability Composition Analysis (2016–2024)

This chart breaks down Il Dong Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 249420 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.91	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.50	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.60	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Il Dong Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Il Dong Pharmaceutical Co Ltd (2016–2024)

The table below shows the annual total liabilities of Il Dong Pharmaceutical Co Ltd from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩429.99 Billion ≈ $291.39 Million	-1.60%
2023-12-31	₩437.00 Billion ≈ $296.15 Million	-4.50%
2022-12-31	₩457.59 Billion ≈ $310.10 Million	-16.56%
2021-12-31	₩548.39 Billion ≈ $371.63 Million	+56.36%
2020-12-31	₩350.73 Billion ≈ $237.68 Million	-2.53%
2019-12-31	₩359.83 Billion ≈ $243.85 Million	+25.01%
2018-12-31	₩287.84 Billion ≈ $195.07 Million	+2.97%
2017-12-31	₩279.55 Billion ≈ $189.45 Million	-0.85%
2016-12-31	₩281.94 Billion ≈ $191.07 Million	--

About Il Dong Pharmaceutical Co Ltd

KO:249420 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$565.84 Million

₩834.97 Billion KRW

Market Cap Rank

#11904 Global

#373 in Korea

Share Price

₩26500.00

Change (1 day)

-3.11%

52-Week Range

₩11430.00 - ₩44300.00

All Time High

₩75500.00